Another Agent for Obesity--Will This Time Be Different?

N Engl J Med. 2015 Jul 2;373(1):82-3. doi: 10.1056/NEJMe1506236.

Authors

Elias S Siraj¹, Kevin Jon Williams

Affiliation

¹ From the Section of Endocrinology, Diabetes and Metabolism, Temple University School of Medicine, Philadelphia (E.S.S., K.J.W.); and the Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden (K.J.W.).

PMID: 26132945
DOI: 10.1056/NEJMe1506236

No abstract available

Publication types

Editorial
Comment

MeSH terms

Female
Glucagon-Like Peptide 1 / analogs & derivatives*
Humans
Hypoglycemic Agents / administration & dosage*
Male
Obesity / drug therapy*

Substances

Hypoglycemic Agents
Glucagon-Like Peptide 1